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The interaction of baicalein with bovine serum albumin (BSA) was investigated with the help of spec-
troscopic and molecular docking studies. The binding afﬁnity of baicalein towards BSA was estimated to
be in order of 105 M1 from ﬂuorescence quenching studies. Negative ΔH° (5.6670.14 kJ/mol) and
positive (ΔS°) (þ79.9670.65 J/mol K) indicate the presence of electrostatic interactions along with the
hydrophobic forces that result in a positive ΔS°. The hydrophobic association of baicalein with BSA di-
minishes in the presence of sodium dodecyl sulfate (SDS) due to probable hydrophobic association of
baicalein with SDS, resulting in a negative ΔS° (40.6570.87 J/mol K). Matrix-assisted laser desorption
ionization/time of ﬂight (MALDI–TOF) experiments indicate a 1:1 complexation between baicalein and
BSA. The unfolding and refolding phenomena of BSA were investigated in the absence and presence of
baicalein using steady-state and ﬂuorescence lifetime measurements. It was observed that the presence
of urea ruptured the non-covalent interaction between baicalein and BSA. The presence of metal ions
(Agþ , Mg2þ , Ni2þ , Mn2þ , Co2þand Zn2þ) increased the binding afﬁnity of ligand towards BSA. The
changes in conformational aspects of BSA after ligand binding were also investigated using circular di-
chroism (CD) and Fourier transform infrared (FT-IR) spectroscopic techniques. Site selectivity studies
following molecular docking analyses indicated the binding of baicalein to site 1 (subdomain IIA) of BSA.
& 2016 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The highly abundant carrier proteins of blood plasma are serum
albumins. They are responsible for the transportation and dis-
tribution of various exogenous and endogenous substances in
blood. They possess an ability to complex with different biologi-
cally active compounds such as drug molecules, fatty acids, hor-
mones, and dyes in the body [1,2]. Bovine serum albumin (BSA) is
a globular protein like human serum albumin and has about 76%
structural homogeneity to human serum albumin [3]. It comprises
three structurally homologous domains (I, II, III), each of which is
further divided into subdomains A and B. Each of the domains is
separated into nine loops (L1-L9) with the help of 17 disulﬁde
bonds. [3–5]. Site 1 and site 2 are situated in subdomain IIA and
IIIA, respectively [3,6]. They are generally called the warfarin and
ibuprofen binding sites, respectively [3,6]. Site 1 has an inclination
for bulkier heterocyclic polar substances, while site 2 generally
favors small aromatic carboxylic acids [7]. BSA has two tryptophanon and hosting by Elsevier B.V. Th
University.
tional Institute of Technology
oy86@nitm.ac.in (A.S. Roy).residues (Trp 134 and Trp 213), among which Trp 213 is situated in
a hydrophobic pocket (site 1, subdomain IIA) and Trp 134 is placed
on the surface region of BSA [3,4,8].
Depending on the potent anti-oxidant, anti-tumor, anti-in-
ﬂammatory and anti-cancer activities of several naturally occur-
ring compounds belonging to the ﬂavonoid family, a large number
of publications have been reported recently by various research
groups [9–12]. The ﬂavone baicalein (5,6,7-trihydroxyﬂavone,
Fig. 1), isolated from Scutellaria baicalensis Georgi, is capable of
reducing the growth of human cancer cells [12]. Baicalein is found
to inhibit the lipoxygenases and reduce cell damage by reactive
oxygen species [13]. Baicalein can protect mice from metabolic
syndrome (persuaded by an elevated fat diet in mice) through an
AMPKα(2)-mediated pathway that involved different intracellular
signaling paths [14]. It is found to prevent the growth of hepato-
cellular carcinoma cell via inhibiting MEK-ERK signaling pathway
[15]. Baicalein is also reported to act as a neuroprotective and anti-
ﬁbrotic agent in the ﬁeld of pharmacology [16,17]. Serum albumins
have the abilities to bind a wide range of small drugs to facilitate
the procedures of drug disposition, transportation and metabo-
lism. The reversible nature of interaction has a direct consequence
in the delivery of these compounds and their metabolites to cells
and tissues [18]. Hence, the binding of baicalein with BSA hasis is an open access article under the CC BY-NC-ND license
Fig. 1. Structure of baicalein.
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binding and its relative bioavailability [19].
The interaction of baicalein with BSA in 20 mM Tris–HCl buffer
of pH 7.4 was reported using ﬂuorescence spectroscopy by Li et al.
[20]. However, the effect of surfactants on the binding of baicalein
with BSA has not been previously looked into. To further probe the
speciﬁc forces of interaction involved in the process, the interac-
tion studies were also performed with varying ionic strength. In
this study we probed the interactions of baicalein with BSA using
the following techniques: UV–vis, steady-state ﬂuorescence, cir-
cular dichroism (CD), Fourier transform infrared spectroscopy (FT-
IR) and matrix-assisted laser desorption ionization/time of ﬂight
(MALDI–TOF) analyses. Thermodynamic parameters (ΔH°, ΔS°
and ΔG°) were estimated from the binding constant values at four
different temperatures. The unfolding and refolding of BSA were
carried out using the chemical denaturant urea in the absence and
presence of baicalein. Finally, molecular docking studies were
conducted to get an idea about the residues involved in the
binding.2. Materials and methods
2.1. Materials
BSA (fraction V), baicalein, TX-100, warfarin and ibuprofen
were purchased from Sigma Co. (St. Louis, MO, USA). SDS, cetyl-
trimethylammonium bromide (CTAB) and other analytical grade
reagents were acquired from Sisco Research Laboratory, India. The
concentration of BSA was measured spectrophotometrically (Shi-
madzu UVPC 2450) by dissolving it in 20 mM phosphate buffer of
pH 7.0 using a molar extinction coefﬁcient of 43800 M1 cm1 at
280 nm [21]. The concentrations of baicalein, warfarin and ibuprofen
were determined on a Shimadzu UVPC 2450 using their respective
molar extinction coefﬁcients: ε323 (baicalein) in ethanol¼
15700 M1 cm1, ε308 (warfarin)¼12500 M1 cm1 [22], and
ε222 (ibuprofen)¼12700 M1 cm1 [23]. All the experiments were
performed in phosphate buffer containing less than 5% alcohol.
2.2. UV–vis study
UV–vis studies for the interaction of baicalein with BSA were
carried out on the Shimadzu UVPC 2450 spectrophotometer
(Shimadzu Corporation, Tokyo, Japan) at 25 °C in the range of 200–
500 nm using a 1 cm quartz cuvette in 20 mM phosphate buffer of
pH 7.0. A 1 mL aliquot of 20 μM baicalein in phosphate buffer was
titrated with consecutive addition of BSA (0, 2.5, 5.0, 7.5, 10, 12.5,
15, 17.5 and 20 μM). Titrations were performed manually with the
help of micro-pipette.
2.3. Fluorescence spectroscopy
The ﬂuorimetric measurements were performed on a HoribaJobin Yvon spectroﬂuorimeter (Fluoromax 4 from Horiba Kyoto,
Japan) with a 1 cm quartz cell. Aliquots of 3 mL of 2 μM BSA were
titrated with the addition of baicalein (0, 1.2, 2.4, 3.6, 4.8, 6.0, 7.2,
8.4, 9.6, 10.8 and 12 μM) at four temperatures (20, 26, 32 and
39 °C) in 20 mM phosphate buffer of pH 7.0. Similar experimental
techniques were reported by Li et al. [20]. The ﬂuorescence spectra
were collected using an excitation wavelength of 295 nm and
emission wavelength in the range of 305–500 nm. The blank
spectra were recorded and subtracted from each BSA-baicalein
complex spectrum. The binding of baicalein with BSA was also
checked in the presence of different potassium chloride (KCl)
concentrations. To see the effect of surfactants on the binding of
baicalein with BSA, the same experiments were performed in the
presence of SDS, CTAB and TX-100. The concentrations of the
surfactants ([SDS]¼8.5 mM, [CTAB]¼1.1 mM and [TX-100]¼
0.035 mM) were taken above their critical micelle concentration
(CMC) in water ([CMCSDS]¼8.2 mM, [CMCCTAB]¼0.92–1.0 mM and
[CMCTX-100]¼0.22–0.24 mM).
The binding constants were also analyzed in the presence of
some common metal ions (Agþ , Ca2þ , Mg2þ , Ni2þ , Mn2þ , Co2þ ,
Zn2þ and Cu2þ). The solutions containing the protein (2 μM) and
the metal ions (100 μM) were incubated for 1 h, and titrated with
successive addition of baicalein (0–12 μM) at 26 °C in 20 mM
phosphate buffer of pH 7.0.
The three-dimensional (3D) spectroscopic experiments were
performed on a Hitachi F-7000 spectroﬂuorometer. The ﬂuores-
cence spectra of BSA (5 mM) in the absence and presence of bai-
calein (25 mM) were obtained using excitation and emission col-
lected in the range of 200–380 nm and 250–500 nm respectively
with a 10 nm increment using excitation and emission slit widths
ﬁxed at 5 nm.
2.4. Site-selectivity study
Warfarin (2 μM) and ibuprofen (2 μM) were incubated with
BSA for 1 h in phosphate buffer of pH 7.0. The samples were ex-
cited at 295 nm (Both excitation and emission slit widths were
ﬁxed at 2 nm) and titrated with the consecutive addition of bai-
calein (0–12 μM). The binding constant values of baicalein with
BSA in the presence of these warfarin and ibuprofen were calcu-
lated using the Eq. (3) as described later.
2.5. Fluorescence resonance energy transfer
The ﬂuorescence quenching spectrum of a 1:1 baicalein-BSA
complex was collected using λex¼295 nm in the range of 305–
500 nm under similar experimental conditions. The UV–vis spec-
trum of 2 μM baicalein at pH 7.0 was recorded on the same
spectrophotometer at 25 °C in the range of 200–500 nm using a
1 cm quartz cuvette.
2.6. MALDI–TOF measurements
The mass spectra were collected on a MALDI–TOF instrument
(Voyager-De Pro from Applied Biosystems, USA) in positive ion
mode. Free BSA (20 mM) and BSA-baicalein complex
(20 mM:120 mM) samples were prepared in experimental buffer
and incubated for 12 h. The samples were mixed with the matrix
solution (20 mg/mL sinapinic acid was dissolved in mixture of
water and HPLC grade acetonitrile containing 0.1% triﬂuoroacetic
acid) in the ratio of 50:50 (v/v). The sample solutions were then
spotted on the steel plate and left for 6 h. MALDI–TOF scanning
was executed keeping the accelerating voltage at 25 kV and mass
range over an m/z from 20 to 120 kD.
Fig. 2. (A) UV–vis spectra of baicalein (20 μM) in the absence and presence of BSA
0–20 μM) in 20 mM phosphate buffer of pH 7.0 (Inset: corresponding Benesi-Hil-
debrand plot) and (B) UV–vis spectra of baicalein, BSA and BSA-baicalein complexes
under the same experimental condition. [BSA]¼[Baicalein]¼25 μM.
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Far-UV CD experiments were carried out on a Jasco-810 auto-
matic spectrophotometer (Japan Spectroscopic Society, Japan)
using a 0.1 cm cell path length at room temperature. The spectra
were scanned in the region of 190–240 nm with a speed of 50 nm/
min and a response time of 4 s. Three different sets of protein
sample (BSA to baicalein molar ratio: 1:0, 1:1 and 1:2) were pre-
pared in buffer. All the CD spectra were corrected with respect to
the blank samples. Secondary structural components of protein
were calculated with the help of DICHROWEB [24].
2.8. Fourier transform infrared spectroscopy
FT-IR experiments were executed on a Nexus 870 FT-IR spec-
trometer (Thermo Nicolet Corporation, Berkeley, USA) equipped
with a zinc selenide (ZnSe) attenuated total reﬂectance (ATR) ac-
cessory, a deuterated triglycine sulfate (DTGS) detector and a KBr
beam splitter at room temperature. 15 mg/mL BSAwas dissolved in
20 mM phosphate buffer and three sets of solutions containing the
BSA:baicalein in different molar ratios (1:0, 1:1 and 1:2) were
prepared. A 256-scan interferogram with 4 cm1 resolution was
used to obtain the spectra after 2 h sample incubation. Blank
spectra were acquired similarly and subtracted from each to get
the different spectra.
Using the method reported by Byler and Susi [25], the
secondary structures of BSA and BSA-baicalein complexes were
estimated from FT-IR data using the position of amide I band
(1700–1600 cm1). To reduce the noise the corrected spectra were
smoothed by a 15-point Savitsky-Golay smooth function [25].
Fourier self deconvolution and second derivative calculation of the
smoothed spectra were used to resolve the major peaks. The
Gaussian curve ﬁtting method was implemented in the region of
1700–1600 cm1 to estimate the total area and area corresponding
to each component of secondary structure.
2.9. Unfolding and refolding phenomena of BSA
Studies on urea (0–7 M) induced chemical denaturation of BSA
in the absence and presence of baicalein were performed with the
help of steady-state ﬂuorescence spectroscopy and lifetime mea-
surements. The BSA (15 μM) and baicalein-BSA (15 μM:15 μM)
systems were excited at 295 nm and the emission was collected in
the range of 300–500 nm. The ﬂuorescence lifetime measurements
were carried out on an EasyLife™ V instrument obtained from
Optical Building Blocks Corporation. The instrument is equipped
with a pulsed width of 1.5 ns and the decay data of the samples
were analyzed using the same software of the instrument. The
ﬂuorescence decays of the samples were recorded in the region of
60–120 ns with an average of 20 using 200 channels. The excita-
tion wavelength was 295 nm to excite speciﬁcally tryptophan re-
sidues of the protein. The average life-time ( τ) can be expressed
according to the following Eq. (1).
τ τ τ< > = + ( )a a 11 1 2 2
2.10. Molecular docking
The 3D crystal structure of BSA (PDB ID: 4F5S) [26] was ob-
tained from the Protein Data Bank [27]. The energy minimized
structures of baicalein and its anion were developed in Sybyl 6.92
(Tripos Inc., St. Louis, USA) using MMFF94 force ﬁeld and MMFF94
charges. The docking of baicalein and its anion with BSA was
performed using FlexX, available in the Sybyl suite and the docked
pose was visualized using PyMol [28].NACCESS was used to calculate the accessible surface area (ASA)
of free and complexed BSA [29]. The change in ASA for the jth
residue was calculated using ΔASAj¼ASAj (free BSA) – ASAj (bai-
calein-BSA). If the loss in ASA of a residue is greater than 10 Å2, it
indicates involvement of that residue in the binding [30].3. Results and discussion
3.1. UV–vis spectral studies
Flavonoids demonstrate two bands, band II (240–280 nm) and
band I (300–400 nm) due to benzoyl (AþC) and cinnamoyl (BþC)
moieties, respectively [31]. The UV–vis spectrum of baicalein
shows two distinct bands at 275 and 338 nm at pH 7.0. Band I is
red shifted (25 nm) in the presence of BSA (Fig. 2A), suggesting the
presence of a speciﬁc interaction between BSA and baicalein. The
spectral broadening of baicalein in the presence of BSA may be due
to the presence of speciﬁc, non-covalent interaction with the
amino acid residues [32]. The ground state equilibrium constant
(Ka) for 1:1 complexation between baicalein and BSA at 25 °C was
estimated according to the Benesi-Hildebrand equation [33].
Δ ε ε ε ε
=
( − )
+
( − ) [ ] ( )A L L K BSA
1 1 1 1
2b f T b f T a
Table 1
The quenching and binding parameters for the interaction of baicalein with BSA at
different temperatures.
Temp. (°C) KSV (105, M1) Kq (1013, M1 s1) Kb (105, M1) n
20 2.31470.098
(R2¼0.97)
4.628 1.54970.019
(R2¼0.99)
1.175
26 1.88270.065
(R2¼0.98)
3.764 1.42570.021
(R2¼0.99)
1.181
32 1.71670.071
(R2¼0.98)
3.342 1.40970.024
(R2¼0.99)
1.081
39 1.62870.043
(R2¼0.99)
3.256 1.33170.019
(R2¼0.99)
1.091
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[BSA] is the concentration of BSA and LT represents the total ligand
concentration. The ΔA is the change in the absorbance at a par-
ticular wavelength. From the plot of 1/ΔA versus 1/[BSA], it is
possible to determine the association constants (Ka) for the bind-
ing, estimated from the ratio of the intercept and the slope (inset
of Fig. 2A). The ground state equilibrium constant (Ka) was found
to be (1.1770.91)105 M1 (R2¼0.99) using the ΔA at 338 nm.
3.2. Fluorescence quenching mechanism
Fluorescence emission spectra of the protein in the absence
and presence of increasing baicalein concentration are given in
Fig. 3A. Baicalein did not exhibit any ﬂuorescence property under
the experimental conditions. The inherent ﬂuorescence of BSA
quenched considerably in the presence of baicalein. The blue shift
(6 nm) in emission spectra after addition of baicalein is an in-
dication of the presence of hydrophobic interaction between bai-
calein and BSA. The quenching mechanism involved here was
discussed with the help of the Stern-Volmer Eq. (3) [34].
τ= + [ ] = + [ ] ( )
F
F
K Q K Q1 1 3q o SV
0
where F0 and F are the ﬂuorescence emission intensities of BSA in
the absence and presence of baicalein, Kq represents the bimole-
cular quenching constant and τ0 (5 ns [10]) is the lifetime of the
ﬂuorescence in the absence of quencher. KSV and [Q] are the Stern-
Volmer quenching constant and the quencher concentration. The
KSV values were obtained by plotting F0/F versus [Q] at four tem-
peratures (Fig. 3B). The Stern-Volmer quenching constants (KSV) at
different temperatures were obtained from the slope of the Stern-
Volmer curve (Fig. 3B) and Kq was calculated by using the fol-
lowing expression KSV¼Kqτ0. The quenching parameters at four
different temperatures are summarized in Table 1. It was observed
that an increase in temperature causes a decrease in KSV values. KSV
and Kq were found in the order of 105 M1 and 1013 M1 s1,
respectively, which matched well with the reported values [20].
This is an indication of the presence of a static quenching me-
chanism. The values of Kq are greater than the limiting value of
21010 M1 s1 [34], which is the maximum possible value of
dynamical quenching constant in aqueous medium.
In addition, the UV–vis data show that the absorption spectrum
of BSA does not overlap with the BSA-baicalein complex spectrumFig. 3. (A) Fluorescence quenching spectra of BSA in the absence and presence of baicale
plot for the interaction of baicalein with BSA at different temperatures: (♦) 293 K, (■) 2(Fig. 2B), indicating the formation of ground state complex be-
tween BSA and baicalein. The presence of BSA causes a red shift of
35 nm in the spectrum of baicalein, which supports the ground
state complexation between BSA and baicalein (Fig. 2B). Thus, the
possibility of involvement of a dynamical quenching mechanism
can be neglected [34].
3.3. Binding constants and binding sites
The following Eq. (4) can be used to compute the binding
constant (Kb) for static quenching interaction between protein and
ligand, if there exists some equivalent independent binding sites
in the protein [35,36]. It reveals the involvement of non-covalent
forces in the binding of baicalein with BSA.
Δ = [ ] + ( )
F
F
n Q Klog log log 4b
The values of Kb were estimated by plotting (Fig. 4A)
Δlog F
F
versus log [Q] and are provided in Table 1. The values of Kb were
found to be in the order of 105 M1 and the number of binding
sites (n) was calculated to be approximately one. The Kb of the
interaction of baicalein with BSA was also estimated as
(1.2370.03)105 (R2¼0.99) and (3.0270.02)105 (R2¼0.99)
M1 at pH 5 and 9, respectively, and the corresponding plot is
given in Fig. S1. The binding constants at different pH conditions
show that Kb values increase with the increase of pH. The higher
the pH values, the higher the binding afﬁnities of baicalein to BSA
are. The associated changes in protein structure from pH 7.0 to pH
4.3 are known as N-F transition (N: native state and F: fastin (0–12 μM) in 20 mM phosphate buffer of pH 7.0 at 26 °C and (B) the Stern-Volmer
99 K (▲) 305 K (▬) 311 K. λex¼295 nm.
Fig. 4. (A) The double-logarithm plot for the interaction of baicalein with BSA at
different temperatures: (♦) 293 K, (■) 299 K (▲) 305 K (▬) 311 K. (B) The van’t Hoff
plot for the corresponding binding process.
Table 2
The binding constants for the interaction of baicalein with BSA in the presence of
different KCl concentrations at 26 °C.
[KCl] (mM) Kb (105, M1, R2¼0.99)
0 1.42570.021
50 1.06870.011
100 0.91270.013
150 0.89170.016
200 0.81870.016 Table 3
The binding constants for the interaction of baicalein with BSA in the presence of
different common metal ions at 26 °C.
Metal ions Kb (105, M1, R2¼0.99)
Without 1.4270.02
Ca2þ 1.4970.01
Mg2þ 1.7170.01
Mn2þ 1.5570.02
Fe2þ 1.9270.02
Co2þ 1.6670.02
Cu2þ 1.5170.03
Ni2þ 1.7570.01
Zn2þ 1.8170.01
Agþ 1.5670.01
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In the F state the secondary structure of BSA became partially
disordered, but in pH 5, no such signiﬁcant structural variation
was reported for BSA [38]. The changes in pH from 7 to 9 caused
N-B transition (B: basic state) in BSA, resulting in a perturbation of
tertiary structure [38]. As per the pKa value (5.3) [39], baicalein
exists as a mixture of neutral and anionic forms at pH 7.0 [40]. It
may be a notable reason for different binding afﬁnities of baicalein
towards BSA at pH 5. Similar results were reported in case of
binding of baicalein with lysozyme by Li et al. [41]. Again theprotein structure was modiﬁed at pH 9.0 and it could be another
prominent factor of different binding afﬁnities of baicalein with
BSA. The results showed that the anionic form had greater afﬁnity
towards BSA. From the point of bond dissociation energy (BDE)
and proton dissociation energy (PDE) calculations, it is already
established that 7 O–H is the easiest removable proton compared
to 5 O–H and 6 O–H [42]. Hence at pH 7, the anion of baicalein (7
O–H) binds to the protein. The most stable anion [42] form of
baicalein was docked with BSA and the results were discussed
later in the molecular docking studies section. The binding con-
stants in the presence of increasing KCl concentrations (Table 2)
are obtained from the double-logarithm plot (Fig. S2A) and were
found to be lower than Kb values without KCl (Fig. S2B). Fig. S2B
shows the decrease in log Kb values with the increase in KCl
concentrations, which reveals the presence of electrostatic inter-
actions between baicalein and BSA.
The effects of SDS, CTAB and TX-100 on the binding of baicalein
with BSA were also studied using ﬂuorescence spectroscopy. The
double-logarithm plots for the interaction of baicalein with BSA in
the presence of the surfactants are given in Fig. S3. The reduction
in values of Kb in case of SDS and CTAB was observed, but in case of
TX-100 small increase occurred (Table S1). The decrease in Kb with
the rise in temperature in all the cases indicates the involvement
of static quenching in the absence and presence of the surfactants.
3.4. Effect of the metal ions on binding
The binding of baicalein with BSA was also analyzed in the
presence of different common metal ions and it was noticed that
the values of binding constant at 26 °C increased (Table 3). The Kb
values were calculated according to Eq. (4) and the plots are pre-
sented in Fig. S4A. The UV–vis spectra of baicalein in the absence
and presence of different metal ions are shown in Fig. S4B and the
changes observed in the baicalein spectrum after addition of the
metal ions indicate metal uptake by the baicalein. The increase of
Kb value in the presence of metal ions can be attributed to the
binding of metal-baicalein complexes to BSA [43,44]. However, the
increase of Kb values for Ca2þand Cu2þ is negligible in comparison
to that for the other metal ions. Li et al. [20] reported that presence
of Cu2þ ion decreased the binding efﬁcacy of baicalein towards
BSA. The changes in UV–vis spectra of BSA in the presence of these
metal ions (Ca2þ , Mg2þ , Ni2þ , Mn2þ , Co2þ , Zn2þand Cu2þ) have
been reported earlier by us [45] and the binding afﬁnities of these
metal ions towards BSA were also estimated in the same report
[45]. It was observed that the binding constants of the metal ions
were less in comparison to the binding afﬁnity of baicalein with
BSA [44]. Another possible reason may be metal ion induced
conformational changes of BSA (changes in UV–vis spectra of BSA
in the presence of the metal ions) that facilitate binding of bai-
calein [43,44].
Table 4
Thermodynamic parameters for the interactions of baicalein with BSA in the ab-
sence and presence of surfactants.
Surfactant Temperature (°C) ΔG° (kJ/mol) ΔH° (kJ/mol) ΔS° (J/mol K)
No surfactant 20 29.09 5.6670.14 þ79.9670.65
26 29.57
32 30.05
39 30.61
SDS 20 27.35 37.7070.24 40.6570.87
26 27.11
32 26.87
39 26.58
CTAB 20 26.81 10.0470.21 þ57.2370.61
26 27.18
32 27.56
39 27.99
TX-100 20 29.87 7.7970.26 þ75.2870.55
26 30.31
32 30.76
39 31.28
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Assuming that the enthalpy change (ΔH°) does not vary ap-
preciably over the temperature range, one can calculate ΔH° and
ΔS° using the van’t Hoff equation:
Δ Δ= − ° + ° ( )K
H
RT
S
R
log
2.303 2.303 5b
The free energy change (ΔG°) of interaction is calculated from
ΔH° and ΔS° values using the following expression:
Δ Δ Δ° = ° − ° ( )G H T S 6
The measured thermodynamic parameters associated with the
interaction were estimated from the temperature dependence of
the binding constant (Kb) using the Eqs. 5 and 6 and are listed in
Table 4. The ΔH° and ΔS° values were determined from the slope
and intercept of the van’t Hoff plots (Fig. 4B and Fig. S5B). Ac-
cording to the sign and magnitude of the above parameters, Ross
and Subramanian [46] analyzed a variety of interactions that play an
important role in the protein-ligand association processes. The ne-
gative ΔH° (5.6670.14 kJ/mol) and positive ΔS° (þ79.9670.65
J/mol K) for the binding of baicalein with BSA are associated with an
electrostatic interaction followed by a hydrophobic force that causes
a positive ΔS° change. We also investigated the type of interaction
taking place between baicalein and surfactant molecules using a
UV–vis study. The UV–vis spectra of baicalein are blue (4 nm) and
red (20 nm) shifted in the presence of SDS and CTAB (Fig. S5A). The
surfactant concentrations used were above their respective CMC
values. These control experiments suggest that baicalein is hydro-
phobically associated with SDS and an electrostatic as well as hy-
drophobic association occurs between baicalein and CTAB.
The hydrophobic association of baicalein with SDS leads to a
decrease in ΔS° (40.6570.87 J/mol K) of the interaction be-
tween baicalein and BSA. As a consequence, the contribution of
ΔH° increases from –(5.6670.14) kJ/mol to –(37.7070.24) kJ/mol,
suggesting that only electrostatic interactions play a key role in
the binding of baicalein with BSA in the presence of SDS. In the
presence of the surfactant CTAB, the ΔH° values of the inter-
actions become more negative, varying from –(5.6670.14) to
–(10.0470.21) kJ/mol and ΔS° changes to þ(57.2370.61) J/mol K
from þ(79.9670.65) J/mol K. This means that an electrostatic
interaction occurs at pH 7 between baicalein and positively
charged CTAB. In solution the availability of baicalein to BSA
decreased due to its interaction with SDS and CTAB, consequently
the binding constant reduced. In the presence of the non-ionicsurfactant TX-100, ΔH° changes to –(7.7970.26) kJ/mol and the
corresponding ΔS° to þ(75.2870.55) J/mol K. The binding con-
stants in the presence of TX-100 remain in the order of 105 M1,
indicating that TX-100, unlike the charged surfactants, does not
have signiﬁcant effect on BSA-baicalein complex. The domain
structure of BSA consists of three peptide segments parallel to
each other forming a very long hydrophobic chain. Nozaki et al.
[47] explained that SDS has a stronger afﬁnity to the proteins
compared to other cationic surfactants and binds to BSA via elec-
trostatic and hydrophobic interactions [48]. It was observed that
low concentrations of SDS stabilized the BSA structure whereas at
higher concentrations it behaved as a denaturant [49]. Subdomain
I (where Trp 134 resides) is more resistant to denaturation, but at
the higher surfactant concentration unfolding of BSA occurs
leading to the exposure of subdomain IIA (site 1, Trp 213 site).
The interaction afﬁnities of the surfactants are reported in the
following order: SDS4CTAB4TX-100 [50]. Hence, it can be con-
cluded that the above order may be due to the relative protein
denaturation order of the surfactants. Baicalein binds to site 1
(subdomain IIA) which is revealed by the site marker displacement
studies as discussed in the following section (Preferential binding
sites). The exposure of subdomain IIA diminishes the hydrophobic
interaction of baicalein with BSA resulting in a negative ΔS°
(40.6570.87 J/mol K). Hence the combined effect of SDS (a de-
naturant and as a ligand of BSA) causes a decrease in the binding
afﬁnity of baicalein to BSA at different temperatures. The nonionic
surfactant TX-100 binds to BSA via polar and nonpolar interaction
modes [51]. Hence in the presence of TX-100 the entropic con-
tributions decreases to some extent and the enthalpic part
increases proportionally. Thus the presence of surfactants affects
the binding afﬁnity and binding mode of baicalein with BSA.
3.6. Preferential binding sites
Many ligand molecules bind to BSA at subdomains IIA and IIIA,
although many lower afﬁnity binding sites also exist. Site 1 (sub-
domain IIA) and site 2 (subdomain IIIA) correspond to the warfarin
and ibuprofen binding sites [52,53]. The emission spectra of BSA
bound to warfarin and ibuprofen excited at 295 nm in the pre-
sence of successive addition of baicalein are presented in
Fig. 5A and B. The binding afﬁnity of baicalein with BSA was es-
timated in the presence of warfarin and ibuprofen under similar
experimental conditions and the corresponding plot is provided in
Fig. 5C. It was found that the Kb values in the presence of warfarin
decreased to (9.3670.51)104 M1 from (14.2570.02)104 M1
at 26 °C. However, in the presence of ibuprofen no such decrease
was observed in the Kb value, (16.6370.158)104 M1. Hence we
conclude that baicalein binds to the hydrophobic site 1 (subdomain
IIA), near to Trp 213 of BSA where warfarin binds, which was also
proven by docking studies (discussed later). Baicalein does not
compete with the ibuprofen binding site in BSA. Recent studies
from our laboratory reveal the same kind of observations indicating
the preferential binding of the ligands to site 1 (subdomain IIA) of
HSA and BSA [54,55].
3.7. Energy transfer parameters
Förster non-radiative energy transfer theory is functional in
many bio-systems to ﬁnd out the distance (d) between the donor
and acceptor. The energy transfer parameters (J(λ), E, R and d) are
calculated based on the equations reported earlier by various re-
search groups [9,11,20] using the values of κ2 (spatial orientation
factor of the dipole), n (refractive index of the medium) and QD
(ﬂuorescence quantum yield of the donor) as 2/3, 1.336 and 0.118,
respectively [34]. The parameter R is the critical distance between
donor and acceptor when the energy transfer efﬁciency (E) is 50%.
Fig. 5. The ﬂuorescence emission spectra of BSA in the presence of (A) warfarin and
(B) ibuprofen with successive addition of baicalein (0–12 μM) in 20 mM phosphate
buffer of pH 7.0. λex¼295 nm, T¼26 °C. (C) Corresponding double-logarithm plots
for the determination of binding constants in the presence of warfarin and
ibuprofen.
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temperatures was determined using the following equation [34].
⎛
⎝⎜
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⎠⎟τ= ( )
−K
R
d 7ET D
1
6
where τD represents the lifetime of donor molecule.
The spectral overlap between the ﬂuorescence emission of the
protein and the UV–vis spectrum of baicalein in the absence and
presence of the surfactants is presented in Fig. S6 and the energy
transfer parameters are enlisted in Table S2. All the distances were
calculated to be less than 7 nm and they were well settled in the
range 0.5R0odo2R0, indicating the higher opportunity of energy
transfer from Trp 213 to the ligands [34]. The rates of energy
transfer in the absence and presence of the surfactants are pro-
vided in Table S2, which indicates that SDS and CTAB lower the
rate with the increase of distance between donor and acceptor, but
the non-ionic TX-100 increases the rate causing a lowering in the
distance.
3.8. MALDI–TOF results
The complexation of baicalein with BSA was also established by
the MALDI–TOF measurements. The pure BSA (from Sigma-Al-
drich) showed the m/z at 66,479.54 Da and it was increased to
66,756.91 Da after complexation with baicalein (Fig. S7), indicating
the possibility of a 1:1 binding between BSA and baicalein. It
supports the value of n obtained from ﬂuorescence data. Similar
types of data were also reported in case of binding of triethoxy
ﬂavone and coumaroyltyramine with human serum albumin
[56,57].
3.9. CD results
The characteristic α-helical conﬁguration of BSA exhibits two
negative bands at 208 and 222 nm in the far UV CD spectrum (Fig.
S8). The binding between baicalein and BSA causes a slight in-
crease in band intensity of the far UV CD without any notable shift
of peaks at different wavelengths. It was found that the α-helical
content of BSA changed from (53.5670.64)% to (54.8170.31)%
and (57.4370.78)% on 1:1 and 1:2 binding with baicalein re-
spectively. The CD studies indicate that baicalein causes an in-
crement in helix of the protein similar to the binding of genistein
with BSA [45].
3.10. FT-IR results
Secondary structural components of proteins are monitored
through the amide I band (1700–1600 cm1). The other compo-
nent in protein structures is the amide II band (1575–1480 cm1)
and provides less conformational sensitivity than amide I region
[58,59]. The spectral shift in peaks of amide I and II bands of BSA at
pH 7 (Fig. 6A) after binding with baicalein at molecular level in-
dicates complexation between protein and ligand.
The secondary structural components of BSA before and after
binding with baicalein were calculated and the results are sum-
marized in Fig. S9. It was found that the percentage of α-helix of
the protein increased from 51% to 53% and 55.7% upon 1:1 and 1:2
binding. The beta sheet content of the protein decreases from 31%
to 27.2% upon binding with baicalein.
3.11. Explanation of hydrophobicity from FT-IR
The symmetric and asymmetric stretching vibrational fre-
quencies of the non-polar groups, CH2 and CH3 (of BSA) in the
region 3000–2800 cm1 [58,59], were shifted during interaction
Fig. 6. FT-IR spectra of BSA and BSA bound with baicalein in the region (A) 1800–
1000 cm1 and (B) 3000–2800 cm1 in 20 mM phosphate buffer of pH 7.0. The
involvement of hydrophobic forces in the binding of baicalein with BSAwas studied
in the region of 3000–2800 cm1. (I) and (II) protein: ligand 1:1 and 1:2,
respectively.
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from 2933 cm1 of BSA to 2938 and 2940 cm1 in 1:1 and 1:2
complexes with baicalein, Fig. 6B). The result indicates the pre-
sence of a hydrophobic association between BSA and baicalein
[59,60].
3.12. Three-dimensional ﬂuorescence
The 3D ﬂuorescence technique can provide some information
regarding the changes in conformation of the proteins during li-
gand binding. The 3D spectrum of BSA (Fig. S10A) exhibits distinct
peak 1 and peak 2 which got quenched after interaction with
baicalein. The peak 1 is the originality of tryptophan and tyrosine
residues and peak 2 presents the spectral properties of polypep-
tide backbone of the protein [45,61]. The results are provided in
Table S3, which clearly indicate that a blue shift (20 nm) in the
presence of baicalein induced some micro-environmental (hy-
drophobic interactions between aromatic ring and the hydro-
phobic residues) and conformational changes in the BSA structure
[45,61].
3.13. Unfolding and refolding study
The denaturation of BSA using urea was carried out in the ab-
sence and presence of baicalein to investigate the structural sta-
bility of BSA. BSA was excited at 295 nm and the emissions were
recorded at 347 nm for the data analyses. The curve of F/F0 againsturea concentrations in the absence of baicalein lies under the
curve when baicalein is present in the medium (Fig. 7C), indicating
the stabilization of BSA even in the presence of chemical dena-
turant [62]. The chemical denaturation of BSA using urea and urea-
baicalein system caused a gradual decrease in the intrinsic ﬂuor-
escence intensity (Fig. 7) of BSA with a red shift of 7 nm in each of
the cases, which resembles the ﬂuorescence emission spectra of L-
tryptophan in aqueous buffer system [63]. The denaturation of BSA
caused the exposure of the buried tryptophan (Trp 213) to a more
polar environment. The refolding experiments of BSA were per-
formed by diluting the actual denatured BSA solution and the
ﬂuorescence intensities along with the peak positions were com-
pared with the native BSA (Fig. 8). The native BSA did not show
any changes in emission maxima except a reduction in the ﬂuor-
escence intensity due to dilution. The diluted denatured BSA in the
absence and presence of baicalein exhibits signiﬁcant blue shift to
347 nm (Fig. 8), indicating the refolding after dilution [64,65].
The steady-state ﬂuorescence measurements of unfolding and
refolding of BSA were also conﬁrmed using ﬂuorescence lifetime
estimation. The lifetime decay for BSA (Fig. S11) was ﬁtted as a bi-
exponential decay function to calculate the lifetime data [66]. The
average ﬂuorescence lifetime of BSA in native state was found to
be (5.2570.21) ns, which was higher than the average lifetime of
L-tryptophan (3.86 ns) in aqueous buffer solution [63]. The de-
crease in the average lifetime of BSA (4.6570.14 ns) in the pre-
sence of baicalein (15 mM) is the indicative of the excited state
complex formation besides a ground state association. The
quenching constants are greater than the limiting value
(21010 M1 s1) of dynamical quenching parameters in aqueous
solution, which rules out the involvement of dynamic quenching.
The presence of 7 M urea leads to a decrease in the average life-
time of BSA both in the absence (2.8170.11 ns) and presence
(2.7870.05 ns) of baicalein. The refolding experiment of BSA from
its denatured state was performed using dilution method and the
lifetime data were considered for further discussion. After dilution
the average lifetime of denatured BSA in the absence and presence
of baicalein goes on increasing to 3.2370.17 ns, and 3.0970.09 ns,
respectively, which clearly signiﬁes the refolding of BSA towards a
partially folded state [63,66]. All the lifetime data are provided in
Table S4.
3.14. Molecular docking results
Molecular docking was executed to substantiate the experi-
mental results. The stereoview of the docked pose of the ligand
with BSA is given in Fig. 9A. The inner hub of BSA (site 1, sub-
domain IIA) is hydrophobic and the entrance of the hub is en-
closed by the polar amino acid residues such as Arg 194, Arg 198,
Arg 217 and Lys 221. The ring C of baicalein is very close to Trp 213
and the distances of its 1-O atom to Trp 213 is 6.6 Å. It can be
concluded that baicalein binds to the hydrophobic pocket near to
Trp 213 (site 1, subdomain IIA) and involvement of Arg 194, Arg
217 and Asp 450 contributes to the electrostatic forces in the
protein-ligand complex. The distances of some residues of BSA
from baicalein are given in Table 5. We calculated ASA for free BSA
and the baicalein-BSA complex and the results are listed in Table 5.
The binding of baicalein within the central hub of different helical
regions of assorted subdomains near to Trp 213 of BSA may be
attributed to the helical stabilization properties of baicalein
[67,68].
The most stable anionic form of the baicalein is docked with
BSA (Fig. 9B). The anion is binding at the same site where mole-
cular baicalein binds. The distances from baicalein and its anion
from the amino acids residues are provided in Fig. 9C and D.
The experimental results show that baicalein anion has a greater
binding afﬁnity towards BSA. The program for energetic analysis of
Fig. 8. Emission spectra of (A) BSA and (B) BSA-baicalein system during refolding
before and after dilution in the presence of urea. λex¼295 nm.
Fig. 7. Fluorescence emission spectra of (A) BSA (15 μM) and (B) BSA-baicalein
(15μM:15 μM) system against various urea concentrations. λex¼295 nm; (C) The
corresponding variations in F/F0 against the increasing concentration of urea.
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theoretical values of free energy of binding for baicalein and its
anionic form with native BSA. The total score (protein-ligandbinding free energy) obtained from the docking studies of baica-
lein and its anion with BSA is 10.79 and 14.63, respectively,
which shows that the anionic form has a higher afﬁnity towards
BSA. PEARLS data (protein-ligand binding free energy) indicates
the similar kind of results where the total protein-ligand binding
energy was calculated to be 7.04 and 10.79 kcal/mol for bai-
calein and its anion, respectively, which is also in favour of the
previous results.4. Conclusion
In this report the binding of baicalein with BSA was studied
using UV–vis, ﬂuorescence, CD, FT-IR and molecular docking
methods. The interaction of baicalein with BSA occurs through
electrostatic interactions along with hydrophobic forces that re-
sults in a positive entropy (þ79.9670.65 J/mol K) change during
complexation. The molecular docking studies in accordance with
the experimental results are sufﬁcient to prove the mode of
binding taking place between BSA and baicalein. The binding af-
ﬁnity of baicalein towards BSA is reduced about 43% in the pre-
sence of 200 mM KCl, indicating the involvement of electrostatic
interaction in the protein-ligand complex. The effects of SDS, CTAB
Fig. 9. The docked conformation of (A) baicalein and (B) baicalein anion with BSA, and the bonding distances of (C) baicalein and (D) its anion from the polar amino acid
residues of the protein.
Table 5
Distances (Å) of some amino acid residues of BSA from baicalein in the docked pose
and the change in accessible surface area (ΔASA) of the interacting residues of BSA
(uncomplexed) and their complex with baicalein.
Residues Distance (Å) ΔASA (Å2)
Arg 194 Nη1 5.0 [4-C¼O] 25.11
Nη2 5.3 [4-C¼O]
Leu 197 14.93
Trp 213 (Nε) 6.6 [1-O] 23.65
7.8 [4-C¼O ]
Arg 217 Nη1 2.7 [4-C¼O] 29.14
Nη2 3.8 [4-C¼O]
Nη1 4.6 [5-O]
Nη2 5.4 [5-O]
Val 342 – 26.01
Asp 450 Oδ1 4.8 [1-O] 30.47
Oδ2 5.3 [1-O]
Ser 453 – 5.32
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the binding constants of baicalein with BSA at different tempera-
tures decreased and SDS suppressed the hydrophobic forces and
the interaction became completely electrostatic in nature. CTAB as
a cationic surfactant also enhanced the electrostatic forces andreduced the contribution of hydrophobic forces. The non-ionic
surfactant TX-100 did not alter the mode of binding between
baicalein and BSA. The presence of metal ions enhanced the
binding afﬁnity of baicalein towards BSA. This indicates a longer
lifetime of baicalein in blood in the presence of metal ions and the
corresponding effectiveness will increase. From the Förster's the-
ory, it has been established that the distance of baicalein from
Trp 213 is 3.27 nm, which predicts that there is a probability of
energy transfer from the donor Trp moiety to the acceptor baica-
lein molecule. The negativeΔG° reveals the spontaneous nature of
complexation processes between baicalein and BSA in the absence
or presence of surfactants at different temperatures. These studies
are signiﬁcant as they provide useful information of the binding of
serum proteins with biologically active components.Acknowledgments
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